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The National Health Service Central Register (NHSCR), part of
the Office for National Statistics, is used by researchers as a source
of follow-up data in prospective trials where cancer incidence
information in required. The completeness of cancer registration
varies in different regions of England and Wales and is dependent
upon cancer site (Villard-Mackintosh et al, 1988; Swerdlow et al,
1993; Warnakulasuriya et al, 1994; Melia et al, 1995). Studies in
the north-west region of England and in Manchester have reported
registration rates for ovarian cancer of 98.5% and 72% respec-
tively (Nwene and Smith, 1982; Mukherjee et al, 1991). No
national studies comparing independent data sources with national
cancer registry statistics for ovarian and fallopian tube cancers
have been reported. This analysis was performed in order to
provide information about the completeness of national registra-
tion of ovarian cancer and to compare it with cancer ascertainment
through independent sources in a research setting.
METHODS
The study population consisted of 22 000 post-menopausal
women who participated in a study of screening for ovarian cancer
which commenced in 1986 (Jacobs et al, 1988, 1993, 1996).
Ovarian and fallopian tube cancers were identified directly (by
screening and postal questionnaire follow-up) and via the
NHSCR. All cases notified from one of these sources were veri-
fied by review of histopathology findings.
Direct follow-up
The research unit documented cases directly through screening
and through responses to three annual questionnaires sent to all
study participants between 1990 and 1993. The questionnaires
requested details of any medical consultations or hospital atten-
dances since registration with the study.
NHSCR follow-up
The study cohort was traced through the NHSCR in July 1997 on
the basis of name, address and date of birth provided in computer-
ized format. The NHSCR provided cancer registration details for
participants who were registered with cancer at any site. In addi-
tion, death certificates were provided for participants who had
died, whatever the cause of death. Ovarian and fallopian tube
cancers ascertained by direct follow-up, but not by the NHSCR in
the initial search in July 1997, were resubmitted several times for
further searches of all central and regional NHSCR data sources.
The final repeat search to locate missed cases took place in May
1998.
In order to allow a comparison of direct and NHSCR follow-up,
the analysis was limited to cases of primary epithelial ovarian and
fallopian tube cancers (ICD-9 code 183) treated in England and
Wales which were diagnosed between 1986 and the last postal
questionnaire follow-up in 1993. Restricting the comparison to
cases diagnosed in this time period allowed a time lag of more than
4 years after diagnosis for information to reach the NHSCR. Cases
of adenocarcinoma of uncertain primary site and of metastatic
disease to the ovaries from other primary sites were excluded.
RESULTS
A total of 49 cases (46 epithelial ovarian and three fallopian tube
cancers) were ascertained through all available sources from 1986
to 1993 (Figure 1). The NHSCR identified 38 of these cases (78%)
of which 31 were registered and seven were documented by death
certification only. Direct follow-up identified 47 cases (96%) of
which 19 were detected through screening and 28 by postal ques-
tionnaire. The two cases identified by the NHSCR only were not
documented directly because the patients did not complete and
return postal questionnaires following diagnosis of their cancers.
The NHSCR failed to document 11 cases which were identified by
direct follow-up. One of these 11 patients was incorrectly regis-
tered as having had mediastinal cancer in the year of diagnosis of
her histologically confirmed ovarian cancer and another patient
was incorrectly registered as having a skin cancer in another year.
Two patients were registered by the NHSCR as having ovarian
cancer on the basis of death certification, but on histopathological
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review were revealed to have metastatic cancers from the breast
and colon to the ovary.
DISCUSSION
This is the first study to assess NHSCR registration of ovarian and
fallopian tube cancers amongst a national cohort of women. The
results suggest that NHSCR records are incomplete as 22% of
cases were not registered. These findings cannot be explained by
incorrect registration under another cancer site as only two of the
11 missed cases were reported by the NHSCR as having cancer of
any site. We have excluded the possibility that the ascertainment
of ovarian and fallopian tube cancers by independent sources was
incorrect by review of histopathological findings in all cases. We
also excluded the possibility that the 11 cases were missed because
of inaccurate information being provided to the NHSCR, by resub-
mitting these cases with carefully checked data for further
searching. It remains possible that the 11 cases not documented by
the NHSCR will eventually be registered and that this study has
underestimated the overall accuracy of the NHSCR. However, a
lengthy time lag of over 4 years was allowed for the delay in infor-
mation reaching the NHSCR, and for the purposes of many
research trials it is not practicable to wait longer than 4 years for
information about cancer registration.
This evidence of incomplete registration of ovarian cancer has
several implications. First, it suggests that published national
cancer statistics for ovarian cancer may underestimate the true inci-
dence of ovarian cancer, as suggested by previous regional studies
(Nwene and Smith, 1982; Mukherjee et al, 1991). It will be impor-
tant to consider this caveat when using NHSCR data for future
epidemiological analyses and to undertake comparisons with other
countries. Second, researchers who plan to use NHSCR follow-up
in prospective trials will need to be aware of the limitations of this
method for documentation of ovarian and fallopian tube cancer. A
considerable period of time must be allowed between completion
of a study and tracing through the NHSCR to allow data to be regis-
tered centrally. Furthermore, it would appear that a complementary
method of follow-up is also required. Our analysis provides encour-
aging evidence for the efficacy of follow-up by postal question-
naire, which also has the benefit of relatively rapid documentation
of cancers. Direct follow-up identified 96% of cases and docu-
mented 11 cases not reported by the NHSCR. Third, it is possible
that the limitations in NHSCR documentation are even greater for
some other cancers than for ovarian cancer. The high mortality to
incidence ratio of ovarian cancer will often provide an opportunity
for ascertainment through death certification even if registration
does not occur at the time of diagnosis. This is less frequently the
case for cancers with a better prognosis than ovarian cancer.
In summary, this study has identified limitations of NHSCR
follow-up in the documentation of ovarian and fallopian tube
cancer. In the research context, some of these limitations can be
overcome by the use of an independent, direct method of follow-
up based on postal questionnaire. Improvements to the organiza-
tion of cancer registration, including computerization, may
improve the situation in due course but at present the limitations of
the NHSCR should be recognized.
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Figure 1 Summary of case ascertainment of ovarian and fallopian tube
cancers in a cohort of 22 000 post-menopausal women from 1986 to 1993 by
the National Health Service Central Register (NHSCR) and by direct follow-
up